Temple Faculty Practice Plan, INC
Temple Faculty Practice Plan, INC was paid $757K by Medicaid between Jul 2019 and Dec 2024, across 17 billing codes. Its largest line is 67028, Intravitreal injection of a pharmacologic agent — 29% of everything it billed.
PHILADELPHIA, PA 19140
Next to other Ophthalmology Physician providers in Pennsylvania
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 530 | $31K | |
| 2020 | 1,204 | $64K | |
| 2021 | 3,252 | $145K | |
| 2022 | 3,796 | $177K | |
| 2023 | 3,575 | $169K | |
| 2024incomplete | 3,437 | $171K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 67028 | Intravitreal injection of a pharmacologic agent | 29% | 1,689 | 1,553 | $219K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 4,993 | 4,722 | $215K |
| 92134 | 14% | 3,604 | 3,462 | $103K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.8% | 2,012 | 1,941 | $74K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 6.2% | 464 | 457 | $47K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.3% | 281 | 271 | $17K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 2.0% | 375 | 361 | $15K |
| 92083 | 2.0% | 295 | 284 | $15K | |
| V2020 | Frames, purchases | 1.9% | 363 | 276 | $15K |
| 92133 | 1.8% | 462 | 451 | $13K | |
| J9035 | Injection, bevacizumab, 10 mg | 1.3% | 464 | 455 | $10K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 100 | 96 | $4K |
5 more codes
| 92020 | <1% | 244 | $3K | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 349 | $3K |
| 92136 | <1% | 34 | $2K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 31 | $1K |
| V2784 | Lens, polycarbonate or equal, any index, per lens | <1% | 34 | $170.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.